Susan Desmond-Hellmann The chancellor of UC-San Francisco since mid-2009, Susan Desmond-Hellmann, a Berkeley alumna (M.P.H.’88) who already has a passel of distinctions, has been named by the daily industry newsletter Fierce Biotech as one of the Top Ten Women in Biotech. She was identified somewhat similarly in 2001, when Fortune magazine included her in its “Top 50 Most Powerful Women in Business” while she was at the height of her for-profit game as executive vice president of product development for Genentech, the South San Francisco biotech giant. Fortune took another look in 2009 and named her as one of the world’s seven most “powerful innovators.” The UC system is well-represented indeed on the 2010 Fierce Biotech list; joining Desmond-Hellman in the Top Ten are Genoptix president and CEO Tina Nova Bennett, who has two UC degrees (a B.S. from Irvine and a Ph.D. from Riverside) and Zosano Pharma CEO and Executive Chair Gail Gaumer Schultze, who earned a B.S. with highest honors in psychobiology from UC-Santa Cruz.